04Mar
Global Private Equity Newsletter - Winter 2020 Edition: Deals in the Life Sciences Sector Article 1: Value Drivers and Risks
As the private equity industry matures, and the deal landscape becomes more competitive, private equity sponsors are becoming more prepared and capable of investing in sectors previously considered overly-regulated, requiring advanced chemistry or...
By:
Dechert LLP
Related
Seyfarth Synopsis: In its introduction to its New Active shooter training materials, the Illinois St...
Read More >
On July 10, 2019, the Japan Fair Trade Commission ("JFTC")'s research center, Competition Policy Res...
Read More >
Can an employer provide health care coverage for its employees by simply setting aside cash for them...
Read More >
As noted in our recent LawFlashes, New Powers for UK Government in Transactions Impacting Public Hea...
Read More >
The surge in popularity of the gig economy in recent years has largely been a positive trend. The gi...
Read More >
As discussed in our previous client alert, on July 31, 2020, through Executive Order 20-181, Govern...
Read More >